Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)
Key facts
- Who runs it
- The University of Queensland
- Where
- Australia and France3 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 300 people enrolled
- Started
- 3 May 2023
- Ended
- 3 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Chlorhexidine gluconate impregnated bordered polyurethane dressing
- Standard bordered polyurethane dressing
- Record updated
- 20 May 2026
Who can take part
- Age
- 6 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- PIVC to be inserted with expected dwell >48 hours
- Provided written and informed consent (patient or carer); Australia only
- ≥6 years of age (due to size of dressing); France only
- ≥18 years of age
Who cannot take part
- Predictably difficult vascular access (IV drug addiction, obesity)
- Known allergy to CHG or transparent dressing adhesives
- Burned, non-intact or scarred skin at the insertion site
- Palliative care patients on end-of-life pathway
- Patient who has already participated in the study
- Placement of a PIVC in an emergency, that does not allow the usual rules of hygiene for insertion to be adhered to; Additional exclusions to Australian study only
- Non-English-speaking patients without interpreter
- Under the care of Child and Family Services and unable to gain consent from case worker (paediatric patients); Additional exclusions to French study only
- Patients not benefiting from the French Social Security scheme or not benefiting from it through a third party,
- Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, adults under legal protection
- Known pregnant or breastfeeding women
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to compare a chlorhexidine impregnated dressing for peripheral intravenous catheters (PIVCs) to the standard dressing currently used in general medical and surgical inpatient wards.
Read full original descriptionShow less
The main questions it aims to answer are:
* Study Feasibility * Occurrence of infectious complications related to the PIVC
Participants will be randomly allocated to receive either of the below dressings to cover and secure their PIVC:
* The standard dressing used at their hospital, or * The intervention dressing which has Chlorhexidine gluconate (CHG) on it
Researchers will compare standard and CHG dressings to see if the presence of CHG improves the occurrence of infectious complications related to the PIVC.
The 2 groups in the trial
- ControlExisting treatment, for comparison
Bordered Polyurethane Dressing
Treatment: Standard bordered polyurethane dressing
- InterventionTreatment being tested
CHG Bordered Polyurethane Dressing
Treatment: Chlorhexidine gluconate impregnated bordered polyurethane dressing
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Protect PIVCs: An Adaptive Randomized Controlled Trial of a Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs).
- Record updated
- 20 May 2026